Top Markets
Coin of the day
Arovella Therapeutics Limited Arovella Therapeutics Limited

Arovella Therapeutics Limited

ALA
Classifica tra le azioni #24892
Arovella Therapeutics Limited, an Australian biotechnology firm, is dedicated... Arovella Therapeutics Limited, an Australian biotechnology firm, is dedicated to developing therapeutic solutions for oncology and central nervous system afflictions, operating both domestically and internationally. Its pipeline features several key assets, including ZolpiMist, an oral spray formulation of zolpidem tartrate for the treatment of short-term insomnia, commercially known by brands such as Ambien or Stilnox. The company is also advancing an invariant natural killer T (iNKT) cell therapy platform specifically designed to target blood cancers. Furthermore, Arovella employs OroMist, an oro-mucosal technology enabling the delivery of various drug classes through absorption in the oral cavity via the cheeks, gums, tongue, or mouth floor, and is developing Anagrelide for cancer treatment. Beyond these, the company is engaged in creating oral sprays to address conditions like migraine headaches, motion sickness, and drug-resistant epilepsy. Arovella maintains a research collaboration agreement with Imperial College London. Established in 1999 and based in Osborne Park, Australia, the company was formerly known as Suda Pharmaceuticals Ltd before rebranding to Arovella Therapeutics Limited in October 2021.
Prezzo delle azioni
$0.04584351
Capitalizzazione di mercato
$55.42M
Variazione (1 giorno)
1.56%
Variazione (1 anno)
-16.04%
Paese
AU
Scambia Arovella Therapeutics Limited (ALA)

Categoria

Storico del prezzo dell'azione per Arovella Therapeutics Limited (ALA)
Prezzo di chiusura più alto: $0.04 il 2026-08-01

Prezzo di chiusura più basso: $1.48 il 2002-01-01
Storico del prezzo dell'azione di Arovella Therapeutics Limited dal 2002 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2026 (TTM) 8.84%
2025 -52.69%
2024 61.67%
2023 305.30%
2022 -35.55%
2021 -8.52%
2020 -23.02%
2019 -54.20%
2018 -63.30%
2017 -14.45%
2016 -33.47%
2015 -53.40%
2014 -26.75%
2013 93.13%
2012 59.05%
2011 -63.96%
2010 4.61%
2009 -5.73%
2008 -54.25%
2007 47.42%
2006 0.76%
2005 -54.49%
2004 -35.11%
2003 206.90%
2002 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
$539.14 35.65%
US
$1.04K 56.21%
NL
$118.70 -18.24%
AU
$760.05 8.39%
CH
$130.43 397.46%
US